spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising

Helga Schweissguth



Editorial

George Grant
 

 

 

Connect with us on Twitter: follow @EBRmagazine
   

   

>Read more publications on Calaméo

Click here to view the digital version of EBR 

 

 

 


 


Click here to view the digital version of EBR BIO-Europe Supplement

 

 

 

ebr
 
 

spacer


Published quarterly in
January, April,
July, and October


 

 
News and Press Releases

"Genome Editing of Immune Cells" - New Lonza Virtual Event

Basel, Switzerland, 06 September 2022 – On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion. The event is a chance for researchers to engage directly with leading voices in the field, keep up to date with the latest CRISPR research and application, and discover tips and tricks for optimized CRISPR editing and screening.
More info >>

 
White Papers
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement